These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12466800)

  • 1. Europe urged to provide boost for bioterror research.
    Abbott A
    Nature; 2002 Dec; 420(6915):450. PubMed ID: 12466800
    [No Abstract]   [Full Text] [Related]  

  • 2. Biodefence: ploughshares into swords.
    Check E
    Nature; 2002 Dec 19-26; 420(6917):736. PubMed ID: 12490912
    [No Abstract]   [Full Text] [Related]  

  • 3. Funding shouldn't rely on competing death tolls.
    Hilbert D
    Nature; 2005 Apr; 434(7036):956. PubMed ID: 15846318
    [No Abstract]   [Full Text] [Related]  

  • 4. Boom, or bust?
    Check E
    Nature; 2003 Dec; 426(6967):598-601. PubMed ID: 14668832
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of generous funding for AIDS research on general biomedical research.
    Dilsaver SC; Coffman JA
    N Engl J Med; 1988 Apr; 318(16):1071-2. PubMed ID: 3352708
    [No Abstract]   [Full Text] [Related]  

  • 6. Has bioterrorism preparedness improved public health?
    Staiti AB; Katz A; Hoadley JF
    Issue Brief Cent Stud Health Syst Change; 2003 Jul; (65):1-4. PubMed ID: 12901394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. War of words deepens divide over biodefence funds.
    Marris E
    Nature; 2005 Apr; 434(7035):813. PubMed ID: 15829930
    [No Abstract]   [Full Text] [Related]  

  • 8. Isolationism is not the answer to bioterrorism.
    Singh JA; Singer PA
    Nature; 2002 Dec; 420(6916):605. PubMed ID: 12478264
    [No Abstract]   [Full Text] [Related]  

  • 9. Joint European plan will tackle Africa's killer diseases.
    McDowell N
    Nature; 2003 Jan; 421(6918):5. PubMed ID: 12511923
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioterrorism defense priorities.
    May T; Silverman R
    Science; 2003 Jul; 301(5629):17. PubMed ID: 12843359
    [No Abstract]   [Full Text] [Related]  

  • 11. Bush asked for $200 million more for global disease fund.
    Nature; 2002 Jun; 417(6890):680-1. PubMed ID: 12066150
    [No Abstract]   [Full Text] [Related]  

  • 12. Guarding HIV-positives against vaccine reaction in the age of bioterror.
    AIDS Alert; 2003 Feb; 18(2):13, 15-7. PubMed ID: 12635589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aid agencies predict victory for HIV unless cash crisis is solved.
    Check E
    Nature; 2004 Jul; 430(6997):279. PubMed ID: 15254499
    [No Abstract]   [Full Text] [Related]  

  • 14. Europe: a challenging niche.
    Nat Rev Microbiol; 2004 Jan; 2(1):3. PubMed ID: 15034993
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioterror and public health infrastructure: a response to commentators.
    May T
    Am J Bioeth; 2006; 6(1):W29-31. PubMed ID: 16423770
    [No Abstract]   [Full Text] [Related]  

  • 16. Public health. Rough-and-tumble behind Bush's smallpox policy.
    Cohen J; Enserink M
    Science; 2002 Dec; 298(5602):2312-6. PubMed ID: 12493889
    [No Abstract]   [Full Text] [Related]  

  • 17. Protest letter accuses health agency of biodefence bias.
    Check E
    Nature; 2005 Mar; 434(7029):7. PubMed ID: 15744263
    [No Abstract]   [Full Text] [Related]  

  • 18. The cost of AIDS.
    Scitovsky AA; Rice DP
    Issues Sci Technol; 1987; 4(1):61-6. PubMed ID: 10312558
    [No Abstract]   [Full Text] [Related]  

  • 19. Allegations of rushed proposals mar disease fund's first awards.
    Check E
    Nature; 2002 Apr; 416(6883):773-4. PubMed ID: 11976634
    [No Abstract]   [Full Text] [Related]  

  • 20. The scientific balance of power.
    Nature; 2006 Feb; 439(7077):646-7. PubMed ID: 16467807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.